Comparison
Why is Alaunos Therapeutics, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0.20%
EBIT Growth (5y)
14.17%
EBIT to Interest (avg)
-35.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.16%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.70
EV to EBIT
-1.12
EV to EBITDA
-1.12
EV to Capital Employed
4.65
EV to Sales
4.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-416.30%
ROE (Latest)
-384.78%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Movement
10What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -2.84 MM
NET PROFIT(HY)
Higher at USD -2.09 MM
ROCE(HY)
Highest at -107.45%
-6What is not working for the Company
NET SALES(HY)
At USD 0 MM has Grown at -60%
RAW MATERIAL COST(Y)
Grown by 101.35% (YoY
CASH AND EQV(HY)
Lowest at USD 3.2 MM
Here's what is working for Alaunos Therapeutics, Inc.
Operating Cash Flow
Highest at USD -2.84 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -2.09 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Here's what is not working for Alaunos Therapeutics, Inc.
Net Sales
At USD 0 MM has Grown at -60%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Cash and Eqv
Lowest at USD 3.2 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 101.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






